—— 要投稿,上万维,轻松学术交流

严正声明

本站非期刊官网,非中介代理,
不向作者收取任何费用!
举报微信:13140028228 冯老师

态度公正、信息求实、投稿自助、使用免费
智新医学(英文)(iNew Medicine)(国际刊号)(OA期刊)(目前免收版面费)
国际号刊 - 季刊
  • 智新医学(英文)(iNew Medicine)(国际刊号)(OA期刊)(目前免收版面费)
  • 复合影响因子:0
  投稿方式:官网投稿
  • 栏目频次
  • 一作占比
  • 单位占比
  • 热词
暂无栏目信息.
暂无一作信息.
暂无单位信息.
暂无关键词信息.
  • 更多

    期刊简介

  • 《智新医学(英文)》(iNew Medicine)(季刊)由安徽医科大学与威利(Wiley)出版集团联合创办。期刊致力于发表医学前沿、临床试验及创新技术领域的高水平研究成果,涵盖人工智能、基因编辑、精准医疗等多个跨学科方向。

  • 基本信息

  • 期刊名称:智新医学(英文)(iNew Medicine)(国际刊号)(OA期刊)(目前免收版面费)
  • 主管单位:
  • 主办单位:安徽医科大学
  • 国内刊号:无CN刊号
  • 国际刊号:ISSN 3067-2775;eISSN 3067-2767
  • 出刊日期:
    期刊定价:
  • 邮发代码:
  • 所在省区:安徽
    邮政编码:
  • 联系地址:

  • 投稿信息

  • 学科分类:临床医学
    版面费用:不收版面费
  • 字数要求:0
    查重要求:-
  • 复合因子:0
    综合因子:0
  • 审  稿 费:
    稿费:待核实
  • 本刊可发:
  • 特殊属性:

  • 联系方式

  • 投稿网址:https://wiley.atyponrex.com/journal/INM3
  • 官网网址:https://onlinelibrary.wiley.com/journal/30672767
  • 电话传真:0551-65161192;65165895(官网)
  • 电子邮箱:inewmed@ahmu.edu.cn(官网)
  • 微信公众号:安徽医科大学

审稿时间:暂无参考数据,审稿时间不确定!

投稿难度:网友分享,仅供参考

见刊周期:-

温馨提示以上只是参考信息,实际情况会根据投稿主题、稿件质量和数量、审稿流程有所差异。想获得更准确信息请联系期刊的编辑部进行咨询。

欢迎点评!让信息更透明,使投稿更轻松!
    • 审稿时间:
      是否录用:
    • 发表排期:
      查重要求:
    • 有无课题:
      有无回复:
    • 我的学历:
      我的职称:
    • 审稿费用:
      版面费用:
    • 稿       费:
      稿件字数:
    • 投稿难度:
    • 该刊可发:
    • 投稿主题:
匿名: 验证码: 点击切换验证码
    • 1、该刊只有国际刊号。

      2、投稿方式:官网投稿。

      3、官网网址:

      https://onlinelibrary.wiley.com/journal/30672767

      (主办单位微信公众号信息)

      4、投稿系统:

      https://wiley.atyponrex.com/journal/INM3

      5、官网电话:0551-65161192;65165895;

      6、官网邮箱:inewmed@ahmu.edu.cn

      7、出刊日期:季刊,一年出版四期。

      8、主办单位微信公众号:安徽医科大学

      9、官网信息:目前不收版面费。

      2025年11月10日星期一

      《智新医学(iNew Medicine)》简介

      【主办单位微信公众号信息】

      安徽医科大学2025年11月8日

      《智新医学(iNew Medicine)》致力于发表医学前沿、临床试验及创新技术领域的高水平研究成果,涵盖人工智能、基因编辑、精准医疗等多个跨学科方向。创刊号的开篇,期刊主编翁建平(Jianping Weng)教授与陈育庆(Y. Eugene Chen)教授联名发表题为《介绍智新医学:推进医疗创新新前沿(Introducing iNew Medicine: Advancing the New Frontiers of Healthcare Innovation)》的创刊词,对创刊背景、宗旨及愿景进行了介绍,描绘了新刊的宏伟蓝图,表示该刊的创立,不仅是科技成果的展示平台,更是创新研究的催化器。通过聚焦生命健康、推动多学科交叉融合,该刊将成为推动学校学科建设与全球医学事业高质量、跨越式发展的重要力量之一。

      据了解,《智新医学(iNew Medicine)》期刊名体现了我校致力于在医学领域实现“创新(Innovative)”“智能(Intelligent)”与“跨学科(Interdisciplinary)”视角的承诺。该刊采用开放获取出版模式,目前免收版面费,且在取得影响因子(IF)之前,校内认可刊发文章享有SCI源期刊Q1区IF3.0 待遇。文章类型包括原创研究论文、特邀综述、观点与展望等。当前重点关注领域包括(但不限于)转化医学、疾病机制、新型治疗药物以及具有里程碑意义的临床试验成果。

      学校诚挚邀请全球相关领域的研究者关注本刊,并投递最具创新性的研究成果。

      Author Guidelines

      【官网信息】

      Preparing Your Submission

      You can read Wiley's Preparing Your Article resource for general information about preparing a submission.

      Free Format submission

      iNew Medicine offers Free Format submission for a simplified and streamlined submission process.

      Free

      Format submission means authors can format their manuscript and

      references in the style or format they would prefer. Wiley will update

      the formatting into the journal style if the manuscript is accepted for

      publication. Review Wiley’s page on Free Format submission to learn more

      about how it works.

      While

      there are no requirements for the formatting you choose, we still ask

      authors to use a consistent format throughout the manuscript and include

      all information necessary for conducting peer review. Information such

      as ORCID IDs and co-author details are necessary for conducting timely

      and ethical peer review. In keeping with the latest guidelines of the

      International Committee of Medical Journal Editors, each author’s

      contribution to the paper is to be quantified.

      Article types

      iNew Medicine publishes the following types of submissions:

      Research Article

      Full-length reports of original research findings.

      Review Article

      Summarizes

      and critically evaluates existing literature on a specific topic.

      Should provide new insights, identify gaps, and suggest future research

      directions..

      Short Communication

      Concise report of data from original research.

      Case Report

      Detailed report of the symptoms, diagnosis, treatment, and follow-up of an individual patient.

      Commentary

      A short article that discusses a specific topic or recent publication.

      Editorial

      Commentary or perspective from the editorial team.

      Letter to the Editor- Comments

      Short, focused responses to articles recently published in the journal or brief discussions on relevant topics.

      Perspective

      Author's opinion or forward-looking commentary on a field.

      Clinical Guidelines

      Evidence-based recommendations from expert panels.

      Meta-Analysis

      Statistical analysis that combines the results of multiple scientific studies.

      Technical Advance

      New methods or protocol updates.

      Study Protocols

      Detailed plans for proposed/ongoing research.

      Data Article

      Publication of datasets with contextual information.

      Focus: Novel findings in medicine/life sciences.

      Word Limit: ≤6,000 words (excl. refs/figures).

      Abstract: Structured, ≤350 words.

      Focus: Critical summaries of recent advances.

      Word Limit: ≤8,000 words (excel. refs/figures).

      Abstract: Unstructured, ≤350 words.

      Focus: Brief reports of novel findings/theories.

      Word Limit: ≤1,500 words (excel. refs/figures).

      Abstract: Unstructured, ≤150 words.

      Focus: Unique/educational clinical cases.

      Word Limit: ≤1,200 words.

      Abstract: Unstructured, ≤100 words.

      Focus: Expert analysis of published work or emerging issues.

      Word Limit: ≤1,000 words.

      Abstract: Not required.

      Focus: Opinions on published articles or field trends (invited).

      Word Limit: ≤1,500 words.

      Abstract: Not required.

      Focus: Concise reports of observations or new ideas.

      Word Limit: ≤1,500 words (excel. refs/figures).

      Abstract: Not required.

      ......

      更多详情:

      https://onlinelibrary.wiley.com/page/journal/30672767/homepage/author-guidelines


    验证码: 点击切换验证码